Study of Safety and Efficacy of AVB-S6-500 in Patients With IgA Nephropathy
Clinical trial NCT04042623 · TERMINATED
Trial details
- NCT number
- NCT04042623
- Sponsor
- Aravive, Inc.
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-27
- Primary completion
- 2020-08-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.